Antigen export during liver infection of the malaria parasite augments protective immunity

mBio

Volumn 5, Issue 4, 2014, Pages 1-11

  Montagna, Georgina N ^a   Beigier Bompadre, Macarena ^a   Becker, Martina ^b   Kroczek, Richard A ^b   Kaufmann, Stefan H E ^a   Matuschewski, Kai ^a,c  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SPOROZOITE VACCINE; OVALBUMIN; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; HEPATITIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; LIVER CELL; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PROTEIN TARGETING; SPOROZOITE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN PRESENTATION; CELL CULTURE; IMMUNOLOGY; LIVER; MALE; METABOLISM; PARASITOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; LIVER; MALE; MICE; MICE, TRANSGENIC; OVALBUMIN; PLASMODIUM BERGHEI; SPOROZOITES;

EID: 84908290034     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01321-14     Document Type: Article

References (54)

1. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. 2008. Immunity to malaria: more questions than answers. Nat. Immunol. 9:725-732. http://dx.doi.org/10.1038/ni.f.205.
2. Good MF. 2013. Immunology. Pasteur approach to a malaria vaccine may take the lead. Science 341:1352-1353. http://dx.doi.org/10.1126/science.1244157.
3. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R. 2009. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361:468-477. http://dx.doi.org/10.1056/NEJMoa0805832.
4. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, van Gemert G, vandeVegte-Bolmer M, van der Ven AJ, Luty AJ, Hermsen CC, Sauerwein RW. 2011. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377:1770-1776. http://dx.doi.org/10.1016/S0140-6736(11)60360-7.
5. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL, VRC 312 Study Team. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359-1365. http://dx.doi.org/10.1126/science.1241800.
6. +T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666. http://dx.doi.org/10.1038/330664a0.
7. Doolan DL, Hoffman SL. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-1462. http://dx.doi.org/10.4049/jimmunol.165.3.1453.
8. Overstreet MG, Cockburn IA, Chen YC, Zavala F. 2008. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an “unnatural” immune response. Immunol. Rev. 225:272-283. http://dx.doi.org/10.1111/j.1600-065X.2008.00671.x.
9. +cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149:966-971.
10. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323-326. http://dx.doi.org/10.1038/341323a0.
11. +cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579-585. http://dx.doi.org/10.1093/intimm/3.6.579.
12. Offeddu V, Thathy V, Marsh K, Matuschewski K. 2012. Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int. J. Parasitol. 42:535-548. http://dx.doi.org/10.1016/j.ijpara.2012.03.011.
13. Nussenzweig V, Nussenzweig RS. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283-334.
14. Hamilton AJ, Davies CS, Sinden RE. 1988. Expression of circumsporozoite proteins revealed in situ in the mosquito stages of Plasmodium berghei by the Lowicryl-immunogold technique. Parasitology 96:273-280. http://dx.doi.org/10.1017/S0031182000058273.
15. Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SH. 2005. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. U. S. A. 102:3022-3027. http://dx.doi.org/10.1073/pnas.0408442102.
16. Cockburn IA, Tse SW, Radtke AJ, Srinivasan P, Chen YC, Sinnis P, Zavala F. 2011. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from Plasmodium in vivo. PLoS Pathog. 7:e1001318. http://dx.doi.org/10.1371/journal.ppat.1001318.
17. Stewart MJ, Nawrot RJ, Schulman S, Vanderberg JP. 1986. Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect. Immun. 51:859-864.
18. +T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur. J. Immunol. 36:1179-1186. http://dx.doi.org/10.1002/eji.200535712.
19. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V. 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444:937-940. http://dx.doi.org/10.1038/nature05361.
20. Grüner AC, Mauduit M, Tewari R, Romero JF, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Crisanti A, Sinnis P, Mazier D, Corradin G, Snounou G, Rénia L. 2007. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2:e1371. http://dx.doi.org/10.1371/journal.pone.0001371.
21. Mauduit M, Tewari R, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Snounou G, Rénia L, Grüner AC. 2010. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect. Immun. 78: 2182-2188. http://dx.doi.org/10.1128/IAI.01415-09.
22. Hafalla JC, Bauza K, Friesen J, Gonzalez-Aseguinolaza G, Hill AV, Matuschewski K. 2013. Identification of targets of CD8(+) T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog. 9:e1003303. http://dx.doi.org/10.1371/journal.ppat.1003303.
23. Hafalla JC, Silvie O, Matuschewski K. 2011. Cell biology and immunology of malaria. Immunol. Rev. 240:297-316. http://dx.doi.org/10.1111/j.1600-065X.2010.00988.x.
24. Riley EM, Stewart VA. 2013. Immune mechanisms in malaria: new insights in vaccine development. Nat. Med. 19:168-178. http://dx.doi.org/10.1038/nm.3083.
25. Hiller NL, Bhattacharjee S, van Ooij C, Liolios K, Harrison T, Lopez-Estraño C, Haldar K. 2004. A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science 306:1934-1937. http://dx.doi.org/10.1126/science.1102737.
26. Marti M, Good RT, Rug M, Knuepfer E, Cowman AF. 2004. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 306:1930-1933. http://dx.doi.org/10.1126/science.1102452.
27. Ingmundson A, Alano P, Matuschewski K, Silvestrini F. 2014. Feeling at home from arrival to departure: protein export and host cell remodeling during Plasmodium liver stage and gametocyte maturation. Cell. Microbiol. 16:324-333. http://dx.doi.org/10.1111/cmi.12251.
28. Singh AP, Buscaglia CA, Wang Q, Levay A, Nussenzweig DR, Walker JR, Winzeler EA, Fujii H, Fontoura BM, Nussenzweig V. 2007. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131:492-504. http://dx.doi.org/10.1016/j.cell.2007.09.013.
29. +T cells in vitro. J. Immunol. 178: 7054-7063. http://dx.doi.org/10.4049/jimmunol.178.11.7054.
30. Balam S, Romero JF, Bongfen SE, Guillaume P, Corradin G. 2012. CSP—a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes. PLoS One 7:e51875. http://dx.doi.org/10.1371/journal.pone.0051875.
31. Murphy SC, Kas A, Stone BC, Bevan MJ. 2013. A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc. Natl. Acad. Sci. U. S. A. 110:6055-6060. http://dx.doi.org/10.1073/pnas.1303834110.
32. Grützke J, Rindte K, Goosmann C, Silvie O, Rauch C, Heuer D, Lehmann MJ, Mueller AK, Brinkmann V, Matuschewski K, Ingmundson A. 2014. The spatiotemporal dynamics and membranous features of the Plasmodium liver stage tubovesicular network. Traffic 15:362-382. http://dx.doi.org/10.1111/tra.12151.
33. Bano N, Romano JD, Jayabalasingham B, Coppens I. 2007. Cellular interactions of Plasmodium liver stage with its host mammalian cell. Int. J. Parasitol. 37:1329-1341. http://dx.doi.org/10.1016/j.ijpara.2007.04.005.
34. Silvie O, Briquet S, Müller K, Manzoni G, Matuschewski K. 2014. Post-transcriptional silencing of UIS4 in Plasmodium berghei sporozoites is important for host switch. Mol. Microbiol. 91:1200-1213. http://dx.doi.org/10.1111/mmi.12528.
35. Hamilton AJ, Suhrbier A, Nicholas J, Sinden RE. 1988. Immunoelectron microscopic localization of circumsporozoite antigen in the differentiating exoerythrocytic trophozoite of Plasmodium berghei. Cell Biol. Int. Rep. 12:123-129. http://dx.doi.org/10.1016/0309-1651(88)90126-9.
36. Hügel FU, Pradel G, Frevert U. 1996. Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes. Mol. Biochem. Parasitol. 81:151-170. http://dx.doi.org/10.1016/0166-6851(96)02701-6.
37. Duffy PE, Sahu T, Akue A, Milman N, Anderson C. 2012. Preerythrocytic malaria vaccines: identifying the targets. Expert Rev. Vaccines 11:1261-1280. http://dx.doi.org/10.1586/erv.12.92.
38. Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodríguez A. 2001. Migration of Plasmodium sporozoites through cells before infection. Science 291:141-144. http://dx.doi.org/10.1126/science.291.5501.141.
39. Leiriao P, Mota MM, Rodriguez A. 2005. Apoptotic Plasmodiuminfected hepatocytes provide antigens to liver dendritic cells. J. Infect. Dis. 191:1576-1581. http://dx.doi.org/10.1086/429635.
40. Renia L, Maranon C, Hosmalin A, Gruner AC, Silvie O, Snounou G. 2006. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses? J. Infect. Dis. 193:163-164. http://dx.doi.org/10.1086/498536.
41. Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B. 2001. Antigen-specific primary activation of CD8+ T cells within the liver. J. Immunol. 166 :5430-5438. http://dx.doi.org/10.4049/jimmunol.166.9.5430.
42. Bertolino P, McCaughan GW, Bowen DG. 2002. Role of primary intrahepatic T-cell activation in the ‘liver tolerance effect’. Immunol. Cell Biol. 80:84-92. http://dx.doi.org/10.1046/j.0818-9641.2001.01048.x.
43. Jenne CN, Kubes P. 2013. Immune surveillance by the liver. Nat. Immunol. 14:996-1006. http://dx.doi.org/10.1038/ni.2691.
44. +T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. U. S. A. 110:9090-9095. http://dx.doi.org/10.1073/pnas.1303858110.
45. +T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection. Infect. Immun. 81:3825-3834. http://dx.doi.org/10.1128/IAI.00570-13.
46. Garg N, Nunes MP, Tarleton RL. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 158:3293-3302.
47. Spielmann T, Montagna GN, Hecht L, Matuschewski K. 2012. Molecular make-up of the Plasmodium parasitophorous vacuolar membrane. Int. J. Med. Microbiol. 302:179-186. http://dx.doi.org/10.1016/j.ijmm.2012.07.011.
48. Goldszmid RS, Coppens I, Lev A, Caspar P, Mellman I, Sher A. 2009. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J. Exp. Med. 206:399-410. http://dx.doi.org/10.1084/jem.20082108.
49. Kaufmann SH, Hess J. 1999. Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development. Immunol. Lett. 65:81-84. http://dx.doi.org/10.1016/S0165-2478(98)00128-X.
50. Gregg B, Dzierszinski F, Tait E, Jordan KA, Hunter CA, Roos DS. 2011. Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii. PLoS One 6:e22936. http://dx.doi.org/10.1371/journal.pone.0022936.
51. Janse CJ, Franke-Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, Matuschewski K, van Gemert GJ, Sauerwein RW, Waters AP. 2006. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol. Biochem. Parasitol. 145:60-70. http://dx.doi.org/10.1016/j.molbiopara.2005.09.007.
52. Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F. 1994. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol. Res. 80:16-21. http://dx.doi.org/10.1007/BF00932618.
53. Buscaglia CA, Coppens I, Hol WG, Nussenzweig V. 2003. Sites of interaction between aldolase and thrombospondin-related anonymous protein in Plasmodium. Mol. Biol. Cell 14:4947-4957. http://dx.doi.org/10.1091/mbc.E03-06-0355.
54. Friesen J, Silvie O, Putrianti ED, Hafalla JC, Matuschewski K, Borrmann S. 2010. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci. Transl. Med. 2:40ra49. http://dx.doi.org/10.1126/scitranslmed.3001058.